Tasimelteon
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB09071 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | bilateral parasagittal parieto-occipital polymicrogyria | KG + DL |
| 2 | insomnia (disease) | KG + DL |
| 3 | amyotrophic lateral sclerosis | KG + DL |
| 4 | endogenous depression | KG + DL |
| 5 | axial spondylometaphyseal dysplasia | KG + DL |
| 6 | monomelic amyotrophy | KG + DL |
| 7 | amyotrophic lateral sclerosis, susceptibility to | KG + DL |
| 8 | lower motor neuron syndrome with late-adult onset | KG + DL |
| 9 | Mills syndrome | KG + DL |
| 10 | amyotrohpic lateral sclerosis type 22 | KG + DL |
| 11 | trichomegaly-retina pigmentary degeneration-dwarfism syndrome | KG + DL |
| 12 | autosomal dominant mitochondrial myopathy with exercise intolerance | KG + DL |
| 13 | lethal arthrogryposis-anterior horn cell disease syndrome | KG + DL |
| 14 | anxiety disorder | KG + DL |
| 15 | sleep disorder, initiating and maintaining sleep | KG + DL |
| 16 | benign paroxysmal torticollis of infancy | KG + DL |
| 17 | childhood apraxia of speech | KG + DL |
| 18 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | KG + DL |
| 19 | rhabdoid tumor | KG + DL |
| 20 | familial generalized lentiginosis | KG + DL |
| 21 | unipolar depression | KG + DL |
| 22 | acute encephalopathy with biphasic seizures and late reduced diffusion | KG + DL |
| 23 | atypical glycine encephalopathy | KG + DL |
| 24 | agoraphobia | KG + DL |
| 25 | faciodigitogenital syndrome | KG + DL |
| 26 | gastrocutaneous syndrome | KG + DL |
| 27 | Charcot-Marie-Tooth disease, demyelinating, type 1G | KG + DL |
| 28 | schizophrenia | KG + DL |
| 29 | major depressive disorder | KG + DL |
| 30 | attention deficit-hyperactivity disorder | KG + DL |
| 31 | surfactant metabolism dysfunction, pulmonary | KG + DL |
| 32 | congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | KG + DL |
| 33 | acromelanosis | KG + DL |
| 34 | retinal dystrophy with or without extraocular anomalies | KG + DL |
| 35 | leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | KG + DL |
| 36 | hydranencephaly (disease) | KG + DL |
| 37 | Moynahan syndrome | KG + DL |
| 38 | congenital disorder of glycosylation with defective fucosylation | KG + DL |
| 39 | osteopathia striata-pigmentary dermopathy-white forelock syndrome | KG + DL |
| 40 | myopia 26, X-linked, female-limited | KG + DL |
| 41 | syndromic myopia | KG + DL |
| 42 | peripheral nerve schwannoma | KG + DL |
| 43 | myopia X-linked | KG + DL |
| 44 | inherited prion disease | KG + DL |
| 45 | sympathetic neurilemmoma | KG + DL |
| 46 | neurofibromatosis | KG + DL |
| 47 | schwannoma of twelfth cranial nerve | KG + DL |
| 48 | Wernicke-Korsakoff syndrome | KG + DL |
| 49 | trigeminal schwannoma | KG + DL |
| 50 | microcystic/reticular schwannoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.